Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Acadia Healthcare Appoints Dr. Nasser Khan to Lead Its CTC Business
Acadia Healthcare Appoints Dr. Nasser Khan to Lead Its CTC Business


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the appointment of Dr. Nasser Khan, M.D., as Operations Group President for its Comprehensive Treatment Center (CTC) business. Dr

DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
DGAP-News: Gerresheimer AG: Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
Humana Finalizes Launch of CenterWell Home Health
Humana Finalizes Launch of CenterWell Home Health


Humana Inc. (NYSE: HUM) has announced the completion of its initiative to rebrand the home health division of Kindred at Home (KAH) as CenterWell Home Health. With today’s announcement, CenterWell

CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix
CenterWell Senior Primary Care to Open 9 Senior-Focused Care Centers in and Around Phoenix


CenterWell Senior Primary Care will open nine new senior-focused primary care centers in the Phoenix area through early 2023, marking the company’s debut in the Arizona market, giving local seniors

AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
AEVIS VICTORIA SA – AEVS.SW: Revenues up by 42.6% to CHF 584.2 million (2021: CHF 409.8 million) in the first semester of 2022
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-Adhoc: Fresenius SE & Co. KGaA: Michael Sen to succeed Stephan Sturm as CEO of Fresenius
DGAP-Adhoc: GN Store Nord A/S: GN Interim Report Q2 2022
DGAP-Adhoc: GN Store Nord A/S: GN Interim Report Q2 2022
DGAP-Adhoc: GN Store Nord A/S: GN Interim Report Q2 2022
DGAP-News: Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
DGAP-News: Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
DGAP-News: Gerresheimer AG: Gerresheimer and Zollner enter into a strategic partnership for electronically controlled medtech systems from a single source
GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise
GN launches new technology platform to address the No.1 hearing aid challenge: hearing speech in noise


GN Hearing, the global leader in hearing aid innovation, today announces the launch of ReSound OMNIA – a new hearing aid platform that will set a new standard in hearing technology and improve how

STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems


STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced its partnership with singer

DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DGAP-News: STRATEC REPORTS RESULTS FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics


NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a peer-reviewed paper published in Nature Genetics

Gerresheimer AG: Gerresheimer invests up to 94 million Dollar in US production facility
Gerresheimer AG: Gerresheimer invests up to 94 million Dollar in US production facility
Gerresheimer AG: Gerresheimer invests up to 94 million Dollar in US production facility
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
DGAP-News: Carl Zeiss Meditec achieves further significant growth in revenue and order intake after nine months of 2021/22
DGAP-News: RHÖN-KLINIKUM AG closes first half of 2022 with increase in revenues
DGAP-News: RHÖN-KLINIKUM AG closes first half of 2022 with increase in revenues
DGAP-News: RHÖN-KLINIKUM AG closes first half of 2022 with increase in revenues
DGAP-News: Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022
DGAP-News: Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022
DGAP-News: Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022
DGAP-Adhoc: Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised
DGAP-Adhoc: Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised
DGAP-Adhoc: Fresenius SE & Co. KGaA: Significantly worsening headwinds at Fresenius Medical Care impact Group net income in FY/22; Fresenius SE & Co. KGaA Group guidance revised
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
DGAP-Adhoc: Fresenius Medical Care AG & Co. KGaA cuts outlook for FY 2022 due to increased headwinds from U.S. labor market situation and global inflation, and withdraws 2025 targets
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish


Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of the Dexcom G6 mobile app in Spanish

Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins
Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins


Waters Corporation (NYSE:WAT) announced it is providing both technology and expertise to help advance plant-based protein science in collaboration with researchers of the Plant Protein Innovation

DGAP-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DGAP-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DGAP-Adhoc: STRATEC REPORTS PRELIMINARY FIGURES FOR FIRST HALF OF 2022 AND CONFIRMS FINANCIAL GUIDANCE
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2
Humana Foundation Announces Scholarship Awards
Humana Foundation Announces Scholarship Awards


The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 40 years, announced 75 winners of college scholarships awarded through The Humana Foundation Scholarship

DGAP-News: Gerresheimer AG: Gerresheimer signs new credit facility in the amount of 150 million Euro
DGAP-News: Gerresheimer AG: Gerresheimer signs new credit facility in the amount of 150 million Euro
DGAP-News: Gerresheimer AG: Gerresheimer signs new credit facility in the amount of 150 million Euro
Acadia Healthcare Names R. David Kelly to Board of Directors
Acadia Healthcare Names R. David Kelly to Board of Directors


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that R. David Kelly has been appointed to serve as an independent director on the Company’s Board of Directors.


This press release